Policymaking based on CERs: changes in costs are not the same as changes in benefits

BACKGROUND: Earlier cost-effectiveness studies showed the cost-effectiveness ratios for pneumococcal vaccination in preventing cases of Bacteremic Pneumococcal Disease (BPD) alone to vary between € 11,000 and € 33,000 per quality-adjusted life year. If vaccination is also assumed to be effective in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ament, Andre JHA, Evers, Silvia MAA
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079908/
https://www.ncbi.nlm.nih.gov/pubmed/15788090
http://dx.doi.org/10.1186/1478-7547-3-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079908/
https://www.ncbi.nlm.nih.gov/pubmed/15788090
http://dx.doi.org/10.1186/1478-7547-3-3

Ejemplares similares